CorMedix Inc. Common Stock (NASDAQ: CRMD) last traded at $7.55, up 2.30% on the session. The quote above updates while this page is open; the figures below are drawn from CorMedix Inc. Common Stock’s own filings and are restated only when a new one is published.
CorMedix Inc. Common Stock trades on NASDAQ under the ticker CRMD. Its market capitalisation is $588.48 million.
Valuation measures for CorMedix Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $588.48M |
|---|---|
| Enterprise value | $775.01M |
| P/E ratio | 3.46 |
| Price / sales | 1.27 |
| Price / book | 1.28 |
| Beta | 1.15 |
Trailing-twelve-month figures tagged in CorMedix Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $462.25M |
|---|---|
| Net income (TTM) | $187.17M |
| EPS (TTM) | $2.18 |
| Gross margin | 82.78% |
| Operating margin | 46.95% |
| Return on equity | 40.62% |
| Cash | $256.69M |
Range and volume for CRMD over the past 52 weeks.
| 52-week high | $13.02 |
|---|---|
| 52-week low | $6.13 |
| Volume | 1.05M |
| Average volume | 1.07M |
| Previous close | $7.38 |
Invest a chosen dollar amount in CorMedix Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell CRMD.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.